Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Ann Oncol. 2019 Feb 1;30(2):346. doi: 10.1093/annonc/mdx814.
No abstract available

Publication types

  • Published Erratum